denenicokin Report issue

Biologics Recombinant protein Experimental
AACT ChEMBL DrugBank MeSH

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

denenicokin | il21 | il-21 | il21 protein, human | interleukin 21 | interleukin-21 | interleukin 21 protein, human | recombinant human interleukin 21 | ril-21 | ril-21; recombinant human interleukin 21

Organizations (6)

Research & Development (6)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (8)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Carcinoma, Renal Cell (Phase 2)

Kidney Neoplasms (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 2)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 2)

Neoplasms by Site (Phase 1)

Ovarian Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 10
  • # of Trial Organizations: 6

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue